Status:
UNKNOWN
The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Schizophrenia
Eligibility:
All Genders
18-60 years
Brief Summary
This is a 49 weeks prospective, non-interventional cohort study. To observe the effect of long-acting injection antipsychotic(LAI), paliperidone palmitate on prevention of recurrence and symptom contr...
Detailed Description
This is a 49 weeks prospective, observational cohort study. Wuhan initiated a project to improve the LAI treatment in schizophrenia patient with violence risk. This observational study will build the ...
Eligibility Criteria
Inclusion
- Patient who has violence risk and in the supervise of government system, and treated with paliperidone palmitate will be invited to the observational study.
Exclusion
Key Trial Info
Start Date :
August 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2021
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT04064476
Start Date
August 18 2019
End Date
September 15 2021
Last Update
February 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuhan mental health center
Wuhan, Hubei, China